About us 關於我們

政府為促進生技醫療產業的發展，經濟部將投入核酸藥物、細胞治療、數位醫療、CDMO等四大領域技術研發，預計四年逾百億元。其中核酸藥物為近年新興之研究領域並在COVID-19的時候證實其可應用性，相信現在與未來可望在台灣創造許多就業機會。若您還對未來研究方向還在觀望且猶豫，不妨來實驗室聊聊，作為未來台灣生技產業中堅力量的你們，相信一定能為這領域的研究挑戰做出貢獻，共勉之！

Our research is focusing on the development of mRNA therapeutics, including mRNA vaccines against COVID-19 (SARS-CoV-2), SFTSV (Severe Fever with Thrombocytopenia Syndrome Virus), and Dengue virus, as well as mRNA-based cancer treatment by CRISPR-Cas9 gene editing and cancer vaccines, including colon cancer, prostate cancer, melanoma, breast cancer, and so on. Moreover, we are also paying attention to the investigation of biomarkers for anti-metastasis and anti-angiogenesis through Micro Western Array (MWA), collaborating with NHRI (國家衛生研究院).